Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gozes

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|December 1, 1995
Developmental changes in purine nucleotide metabolism in cultured rat astrogliaE Zoref-Shani, Y Bromberg, G Lilling, et al.
Somatic Cell and Molecular Genetics|July 1, 1987
Sequential expression in the nervous system of c-myb and VIP genes, located in human chromosomal region 6q24I Gozes, H Nakai, M Byers, et al.
Neuroscience Letters|February 14, 1994
Adrenalectomy decreases vasoactive intestinal peptide mRNA levels in the rat suprachiasmatic nucleusI Gozes, R Avidor, E Giladi, et al.
Journal of Neurochemistry|December 3, 1999
Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced deathG W Glazner, A Boland, A E Dresse, et al.
Brain Research|January 20, 1992
Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonistJ R Glowa, L V Panlilio, D E Brenneman, et al.
Journal of Molecular Neuroscience : MN|January 1, 1994
Inhibition of human neuroblastoma growth by a specific VIP antagonistG Lilling, Y Wollman, M N Goldstein, et al.
Endocrinology|July 19, 2001
IGF-I as a mediator of VIP/activity-dependent neurotrophic factor-stimulated embryonic growthS J Servoss, S J Lee, G Gibney, et al.
Annals of the New York Academy of Sciences|February 24, 2001
A novel VIP responsive gene. Activity dependent neuroprotective proteinI Gozes, R Zamostiano, A Pinhasov, et al.
Cancer|October 12, 2001
A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell linesE Gelber, R Granoth, M Fridkin, et al.
The Journal of Clinical Investigation|July 15, 1997
Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brainP Gressens, S Marret, J M Hill, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|December 1, 1995
Developmental changes in purine nucleotide metabolism in cultured rat astrogliaE Zoref-Shani, Y Bromberg, G Lilling, et al.
Somatic Cell and Molecular Genetics|July 1, 1987
Sequential expression in the nervous system of c-myb and VIP genes, located in human chromosomal region 6q24I Gozes, H Nakai, M Byers, et al.
Neuroscience Letters|February 14, 1994
Adrenalectomy decreases vasoactive intestinal peptide mRNA levels in the rat suprachiasmatic nucleusI Gozes, R Avidor, E Giladi, et al.
Journal of Neurochemistry|December 3, 1999
Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced deathG W Glazner, A Boland, A E Dresse, et al.
Brain Research|January 20, 1992
Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonistJ R Glowa, L V Panlilio, D E Brenneman, et al.
Journal of Molecular Neuroscience : MN|January 1, 1994
Inhibition of human neuroblastoma growth by a specific VIP antagonistG Lilling, Y Wollman, M N Goldstein, et al.
Endocrinology|July 19, 2001
IGF-I as a mediator of VIP/activity-dependent neurotrophic factor-stimulated embryonic growthS J Servoss, S J Lee, G Gibney, et al.
Annals of the New York Academy of Sciences|February 24, 2001
A novel VIP responsive gene. Activity dependent neuroprotective proteinI Gozes, R Zamostiano, A Pinhasov, et al.
Cancer|October 12, 2001
A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell linesE Gelber, R Granoth, M Fridkin, et al.
The Journal of Clinical Investigation|July 15, 1997
Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brainP Gressens, S Marret, J M Hill, et al.
Pageof 14